AOA dx

Akrivis GD
TM
The first liquid biopsy test that accurately enables early diagnosis of ovarian cancer through the analysis of tumor marker gangliosides.
We are
AOA.
AOA Dx is a team of entrepreneurs and experts that brings innovative, impactful and cost-effective medical technologies from research and development into the hands of providers and patients.
The co-founders have worked together for over 8 years, combining 30 years of experience bringing products from concept to commercialization across global markets.
Learn more about our mission and company
More than 90% of new discoveries in medical innovation stay in research within an academic setting and are never commercialized and widely adopted to help patients
We want to change that
"Our goal is to work closely with scientific innovators to make their products widely available to impact clinical practice today"